Clinical trial
Comparison of the Sevoflurane EC50 Values for Laryngeal Mask Airway Supreme Versus Laryngeal Mask Airway ProSeal Insertion During Target-controlled Infusion of Remifentanil. A Randomized Trial
NCT03003377 is registered in ClinicalTrials.gov with Hospital General Universitario Gregorio Marañon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Sevoflurane EC50 Values for Laryngeal Mask Airway Supreme Versus Laryngeal Mask Airway ProSeal Insertion During Target-controlled Infusion of Remifentanil. A Randomized Trial
- Lead sponsor
- Hospital General Universitario Gregorio Marañon
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2014
- Completion date
- October 31, 2015
- Enrollment
- 45 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
sevoflurane